{"article":{"annotation":{"article_id":"canada-health-product-authorizations-q3-2026","available_at":"2026-10-16T16:20:36.543365Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"5e92b61235936df03265bf91e72645216cd61ea66c602734b29c7195e05e141a","input_sha256":"2dfb9d034a593e439a50b5017769dc40bf6b773d9e0fe42c31cbb7216921aed3","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"CA","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html"]}],"geometry":null,"id":"iso3166-1:CA","kind":"country-or-area","labels":{"ar":"كندا","en":"Canada","es":"Canadá","fr":"Canada"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:07000000","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: Health","source_urls":["https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html"]}],"method":"controlled-rules-v1","rule_id":"health","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=pt","category":"health","content":{"key_points":[],"paragraphs":["A Health Canada informou que autorizou 16 novos medicamentos sujeitos a receita, 33 medicamentos genéricos ou biossimilares e 540 novos dispositivos médicos entre 1 de julho e 30 de setembro de 2026. A atualização trimestral de 15 de outubro também descreveu a pressão sobre a análise de medicamentos devido ao aumento de pedidos cada vez mais complexos.","O departamento está a dar prioridade a alguns pedidos de genéricos e a avançar na modernização das regras de ensaios clínicos. Uma proposta para medicamentos destinados a crianças e jovens reduziria os prazos de análise de 300 para 180 dias; continuava em consulta até 23 de outubro e não era ainda uma regra final."],"sections":[]},"corrections":[],"country":"CA","data":{"blocks":[{"description":{"ar":"أعداد الأدوية والأجهزة الطبية المرخصة من 1 يوليو إلى 30 سبتمبر 2026.","de":"Zahl der vom 1. Juli bis 30. September 2026 zugelassenen Arzneimittel und Medizinprodukte.","en":"Counts of drugs and medical devices authorized from July 1 through September 30, 2026.","es":"Número de medicamentos y dispositivos médicos autorizados del 1 de julio al 30 de septiembre de 2026.","fr":"Nombre de médicaments et de dispositifs médicaux autorisés du 1er juillet au 30 septembre 2026.","pt":"Número de medicamentos e dispositivos médicos autorizados de 1 de julho a 30 de setembro de 2026.","tr":"1 Temmuz–30 Eylül 2026 arasında onaylanan ilaç ve tıbbi cihaz sayıları."},"id":"canada-health-product-authorizations-q3-2026","items":[{"basis":"observed","label":{"ar":"أدوية موصوفة جديدة","de":"Neue verschreibungspflichtige Arzneimittel","en":"New prescription drugs","es":"Nuevos medicamentos con receta","fr":"Nouveaux médicaments sur ordonnance","pt":"Novos medicamentos sujeitos a receita","tr":"Yeni reçeteli ilaçlar"},"measure":{"aggregation":"cumulative","frequency":"quarterly","geography":"canada","id":"canada-new-prescription-drug-authorizations-2026-q3","periodRole":"reference-period","unitCode":"count"},"period":"2026-09","unit":"count","value":16},{"basis":"observed","label":{"ar":"الأدوية الجنيسة والبدائل الحيوية","de":"Generika und Biosimilars","en":"Generic and biosimilar drugs","es":"Medicamentos genéricos y biosimilares","fr":"Médicaments génériques et biosimilaires","pt":"Medicamentos genéricos e biossimilares","tr":"Jenerik ve biyobenzer ilaçlar"},"measure":{"aggregation":"cumulative","frequency":"quarterly","geography":"canada","id":"canada-generic-biosimilar-drug-authorizations-2026-q3","periodRole":"reference-period","unitCode":"count"},"period":"2026-09","unit":"count","value":33},{"basis":"observed","label":{"ar":"أجهزة طبية جديدة","de":"Neue Medizinprodukte","en":"New medical devices","es":"Nuevos dispositivos médicos","fr":"Nouveaux dispositifs médicaux","pt":"Novos dispositivos médicos","tr":"Yeni tıbbi cihazlar"},"measure":{"aggregation":"cumulative","frequency":"quarterly","geography":"canada","id":"canada-medical-device-authorizations-2026-q3","periodRole":"reference-period","unitCode":"count"},"period":"2026-09","unit":"count","value":540}],"methodology":{"ar":"أُخذت الأعداد من البيان الفصلي لوزارة الصحة الكندية المؤرخ 15 أكتوبر 2026؛ وتُعرض الفئات الواردة في المصدر فقط.","de":"Die Zahlen stammen aus der Quartalsmitteilung von Health Canada vom 15. Oktober 2026; dargestellt werden nur die dort genannten Kategorien.","en":"Counts are taken from Health Canada’s quarterly release dated October 15, 2026; only categories stated in the source are shown.","es":"Los recuentos proceden del comunicado trimestral de Health Canada del 15 de octubre de 2026; solo se muestran las categorías indicadas en la fuente.","fr":"Les nombres proviennent du communiqué trimestriel de Santé Canada daté du 15 octobre 2026; seules les catégories indiquées par la source sont présentées.","pt":"As contagens provêm do comunicado trimestral da Health Canada de 15 de outubro de 2026; são apresentadas apenas as categorias indicadas na fonte.","tr":"Sayım, Health Canada'nın 15 Ekim 2026 tarihli üç aylık açıklamasından alınmıştır; yalnızca kaynakta belirtilen kategoriler gösterilir."},"sourceUrls":["https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html"],"title":{"ar":"تراخيص وزارة الصحة الكندية في الربع الثالث من 2026","de":"Zulassungen von Health Canada im dritten Quartal 2026","en":"Health Canada Q3 2026 authorizations","es":"Autorizaciones de Health Canada en el T3 de 2026","fr":"Autorisations de Santé Canada au T3 2026","pt":"Autorizações da Health Canada no terceiro trimestre de 2026","tr":"Health Canada Q3 2026 yetkilendirmeleri"},"type":"metrics","updatedAt":"2026-10-16T15:49:08Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026/data/canada-health-product-authorizations-q3-2026?lang=pt&format=csv","json":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026/data/canada-health-product-authorizations-q3-2026?lang=pt&format=json"},"id":"canada-health-product-authorizations-q3-2026"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Ilustração conceitual de saúde pública, pesquisa e dados conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"pt","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-6ab1799d-dd58-5779-b460-49c93284da84","event_period":"2026-09","event_period_basis":"event-or-reference-period","id":"canada-health-product-authorizations-q3-2026","image":null,"importance":0.6,"language":"pt","modified_at":"2026-10-16T16:20:29+00:00","publication_basis":"publication-record","published_at":"2026-10-16T16:20:29+00:00","reading_minutes":1,"region":"world","section_illustration":{"alt":"Ilustração conceitual de saúde pública, pesquisa e dados conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"pt","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"canada-health-product-authorizations-q3-2026","sources":[{"checkedAt":"2026-10-16","name":"Health Canada","publishedAt":"2026-10-15","url":"https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html"}],"summary":"A autoridade também autorizou 33 medicamentos genéricos ou biossimilares entre julho e setembro e propôs análises mais rápidas para medicamentos pediátricos.","text":"A autoridade também autorizou 33 medicamentos genéricos ou biossimilares entre julho e setembro e propôs análises mais rápidas para medicamentos pediátricos.\n\nA Health Canada informou que autorizou 16 novos medicamentos sujeitos a receita, 33 medicamentos genéricos ou biossimilares e 540 novos dispositivos médicos entre 1 de julho e 30 de setembro de 2026. A atualização trimestral de 15 de outubro também descreveu a pressão sobre a análise de medicamentos devido ao aumento de pedidos cada vez mais complexos.\n\nO departamento está a dar prioridade a alguns pedidos de genéricos e a avançar na modernização das regras de ensaios clínicos. Uma proposta para medicamentos destinados a crianças e jovens reduziria os prazos de análise de 300 para 180 dias; continuava em consulta até 23 de outubro e não era ainda uma regra final.","title":"A Health Canada autorizou 16 novos medicamentos sujeitos a receita e 540 dispositivos no T3","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/canada-health-product-authorizations-q3-2026"}],"url":"https://newsverum.com/pt/news/canada-health-product-authorizations-q3-2026"},"version":"1"}